Tissue-agnostic RET inhibition: can you trust your target?

Lancet Oncol. 2022 Oct;23(10):1235-1237. doi: 10.1016/S1470-2045(22)00556-3. Epub 2022 Sep 12.

Authors

Angelica D'Aiello¹, Balazs Halmos²

Affiliations

¹ Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA.
² Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA. Electronic address: [email protected].

PMID: 36108663
DOI: 10.1016/S1470-2045(22)00556-3

No abstract available

Publication types

Comment

MeSH terms

Humans
Proto-Oncogene Proteins c-ret* / genetics
Trust*

Substances

Proto-Oncogene Proteins c-ret
RET protein, human